1 Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Gregory University, Uturu, Abia State, Nigeria.
2 Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Nnewi Campus, Nigeria.
3 Department of Medical Laboratory Science, Faculty of Health Science and Technology, Nnamdi Azikiwe University, Nnewi Campus, Nigeria.
4 Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, Alex Ekwueme Federal University, Ndufu Alike Ebonyi State, Nigeria.
5 Department of Pharmacology, Prince Abubakar Audu University, Anyigba, Kogi State, Nigeria.
6 Department of Pharmacology, School of Medicine, Kabale, University, Uganda.
Research Article
GSC Biological and Pharmaceutical Sciences, 2024, 26(03), 159–169.
Article DOI: 10.30574/gscbps.2024.26.3.0085
Received on 28 January 2024; revised on 16 March 2024; accepted on 19 March 2024
Aim: Medicago sativa leaf is traditionally used for the treatment of gastrointestinal disorders in Nigeria. This research investigates the in vivo antidiarrheal activity of M. sativa (Alfalfa) leaf extract in Wistar rats.
Method: The study employed three models: castor oil-induced diarrhea, gastrointestinal motility (charcoal meal), and castor oil-induced intestinal fluid accumulation. The phytochemical analysis as well acute toxicity tests were carried out in the leaf extract.
Results: The results demonstrate a dose-dependent and significant antidiarrheal effect of M. sativa leaf extract. In the castor oil-induced diarrhea model, the extract reduced fecal frequency, delayed onset, and lowered severity, with the highest effect at 600 mg/kg compared to a positive control (Loperamide). Gastrointestinal motility was inhibited by the extract in a dose-dependent manner, achieving maximum effect at 600 mg/kg, comparable to atropine sulfate. The castor oil-induced intestinal fluid accumulation model revealed a significant decrease in fluid volume at 600 mg/kg, exhibiting a potent inhibitory effect. The oral LD50 values obtained were greater than 5000 mg/kg in rats
Conclusion: This study provides compelling evidence of Medicago sativa leaf extract's potential as an antidiarrheal agent in Wistar rats. Further investigations could explore its mechanism of action and safety profile, contributing valuable insights to the development of novel antidiarrheal therapies.
Medicago sativa; Ethanol leaf extract; Antidiarrheal activity; Gastrointestinal motility; Enteropooling; Wistar rats
Preview Article PDF
Anele Donatus Onyebuchi, Akuodor Godwin Christian, Okoroama Casmir Emeka, Unaeze Bright Chukwuebuka, Ajegi Innocent Fountain, Iganga Ogbonnaya Nnabuike and Nwokike Matthew Onyemaechi. Evaluation of Medicago sativa ethanol leaf extract for antidiarrheal activity in Wistar rats. GSC Biological and Pharmaceutical Sciences, 2024, 26(3), 159-169. Article DOI: https://doi.org/10.30574/gscbps.2024.26.3.0085